|
|
|
Volumn 83 Suppl 1, Issue , 2004, Pages
|
|
P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTARABINE;
DAUNORUBICIN;
DAV REGIMEN;
ETOPOSIDE;
GLYCOPROTEIN P;
ACUTE DISEASE;
ARTICLE;
HUMAN;
METABOLISM;
MIDDLE AGED;
MYELOID LEUKEMIA;
PHASE 1 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
TREATMENT OUTCOME;
ACUTE DISEASE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE III;
CYTARABINE;
DAUNORUBICIN;
ETOPOSIDE;
HUMANS;
LEUKEMIA, MYELOID;
MIDDLE AGED;
P-GLYCOPROTEIN;
TREATMENT OUTCOME;
|
|
EID: 3042617882
PISSN: 09395555
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
